HOME >> BIOLOGY >> NEWS
Manipulation of epigenome turns off as many genes as it turns on

Agents believed to selectively "restart" genes that limit cancer's growth -- a potential treatment option already in early clinical studies -- instead turn off as many genes as they turn on, a team of researchers from the National Cancer Institute and Johns Hopkins has discovered.

"We don't know what effect all these changes might have, but it's clear that when scientists are looking only at the agents' effects on a particular gene or a few particular genes, they aren't seeing the whole picture," says Andrew Feinberg, M.D., M.P.H., King Fahd Professor of Medicine at Johns Hopkins. Their report appears in the October issue of Cancer Cell.

The research team probed the global effects of each of three approaches to unhooking methyl groups from genes' DNA. Cells normally use methyl groups to "mark" certain genes, indicating whether their instructions should or shouldn't be used for making proteins, but the marks are frequently disrupted in cancer cells.

For example, in cancer cells genes that normally stifle cell growth -- so-called tumor suppressor genes -- are shut down because extra methyl groups are hanging on to them. If these extra methyl groups could be removed, the thinking has gone, the gene could be restarted and the cancer slowed or stopped.

But the new work shows that while the agents tested do restart cancer-suppressing genes, they also knock methyl groups off other genes. Moreover, some of the unexpectedly affected genes are turned on, but an equal number -- hundreds -- of other genes are turned off.

The findings don't mean automatic failure for clinical trials of so-called demethylation agents, but they do indicate that careful attention should be paid to results of laboratory experiments and clinical trials that use the agents, since so many genes are affected, says Feinberg.

"It was kind of assumed that removing methyl groups would turn some genes on and others off, but the deactivation s
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
18-Oct-2004


Page: 1 2 3

Related biology news :

1. In a technical tour de force, Salk scientists take a global view of the epigenome
2. Cancer scientists call for a large-scale human epigenome project
3. OHSU turns mouse into factory for human liver cells
4. Leukemia drug turns mini-molecules up, cancer genes down
5. Jefferson researchers uncover new way nature turns genes on and off
6. Vax and Pax: Taking turns to build an eye
7. UC Riverside researchers show how the brain turns on innate behavior
8. NIH turns to FSU for top research on learning disabilities
9. Research shows how visual stimulation turns up genes to shape the brain
10. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
11. Undergraduate researcher turns up the heat on hibernation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... ... September 05, 2018 , ... Following ... manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have ... cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... (NASDAQ: AMDA) to purchase its commercial spine business, which includes its complete portfolio ... to the spine that result from it. The deal will make CTL Medical ...
(Date:8/31/2018)... ... August 30, 2018 , ... R3 Stem Cell, the ... for new clients. The freezers are very convenient for practices to maintain regenerative ... consist of amniotic and umbilical cord tissue. They are stored at -80 degrees ...
Breaking Biology News(10 mins):
(Date:8/14/2018)... YORBA LINDA, Calif. (PRWEB) , ... August 14, ... ... opioid, an important drug for treating opioid use disorder. BUP is often prescribed ... parenteral use and diversion. , In this webinar, participants will learn from ...
(Date:8/11/2018)... VINELAND, N.J. (PRWEB) , ... August 10, 2018 , ... ... or fracturing while under pressure. The Explosion Protection Chamber for High-Pressure NMR & ... a new level of safety to the laboratory. , High-pressure experiments have significantly ...
(Date:8/9/2018)... ... 2018 , ... ActX introduces GenoACT(sm), a Genetic Clinical Decision ... talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by ... medical impact of a patient’s genetic variants , 2. Educational information for clinicians, ...
(Date:8/9/2018)... ... August 08, 2018 , ... Since their establishment in 2012, ... with a team nearly double its’ size from last year, the company is thrilled ... turned heads and impressed crowds at a private product launch event during the ...
Breaking Biology Technology:
Cached News: